NAMPT inhibitor RPT1G demonstrated favorable safety and significant target engagement in first-in-human studyCompany to present Trial in Progress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results